Advances in imaging in the work-up of head and neck cancer patients

Oral Oncology

Volumn 45, Issue 11, 2009, Pages 930-935

  de Bree, Remco ^a   Castelijns, Jonas A ^a   Hoekstra, Otto S ^a   Rene Leemans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Head and neck cancer; Imaging; PET, MRI, sentinel node; Pretreatment; Work up

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AUTOFLUORESCENCE IMAGING; CANCER PATIENT; CANCER SCREENING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISTANT METASTASIS; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349972053     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.07.011     Document Type: Review

References (45)

1. O'Sullivan B., and Shah J. New TNM staging criteria for head and neck tumors. Semin Surg Oncol 21 (2003) 30-42
2. Schmidt G.P., Kramer H., Reiser M.F., and Glaser C. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Top Magn Reson Imaging 18 (2007) 193-202
3. Swinson B., Jerjes B., El-Maaytah M., Norris P., and Hopper C. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol 42 (2006) 221-228
4. Betz C.S., Stepp H., Janda P., Arbogast S., Grevers G., Baumgartner R., et al. A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 97 (2002) 245-252
5. Roh J.L., Yeo N.K., Kim J.S., Lee J.H., Cho J.J., Choi S.H., et al. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol 43 (2007) 887-893
6. Regelink G., Brouwer J., de Bree R., Pruim J., van der Laan B.F.A.M., Vaalburg W., et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med 29 (2002) 1024-1030
7. Rusthoven K.E., Koshy M., and Paulino A.C. The role of fuorodeoxyglucose positron emission tomography in cervical lymph nodes metastases from unknown primary tumor. Cancer 101 (2004) 2642-2649
8. Padovani D., Aimoni C., Zucchetta P., Paluzzi A., and Pastore A. 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 266 (2009) 267-271
9. de Bondt R.B.J., Nelemans P.J., Hofman P.A.M., Casselman J.W., Kremer B., Engelshoven, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64 (2007) 266-272
10. Kyrzas P.A., Evangolou E., Denaxa Kyza D., and Ionnidas J.P.A. 18F-Fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 100 (2008) 712-720
11. Van den Brekel M.W.M., Castelijns J.A., Stel H.V., Luth W.J., Valk J., van der Waal I., et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 180 (1991) 457-461
12. Righi P.D., Kopecky K.K., Caldemeyer K.A., Ball V.A., Weisberger E.C., and Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 19 (1997) 601-610
13. Takes R.P., Righi P., Meeuwis C.A., Manni J.J., Knegt P., Marres H.A.M., et al. The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 40 (1998) 1027-1032
14. Brouwer J., de Bree R., Comans E.F.I., Castelijns J.A., Hoekstra O.S., and Leemans C.R. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck; is it likely to be superior. Eur Arch Otorhinolaryngol 261 (2004) 479-483
15. Wensing B.M., Vogel W.V., Marres H.A.M., Merkx M.A.W., Postema E.J., and Oyen W.J.G. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116 (2006) 809-813
16. Krabbe C.A., Dijkstra P.U., Pruim J., van der Laan B., van der Wal J.E., Gravendaal J.P., et al. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases. Oral Oncol 44 (2008) 31-36
17. Ng S.H., Yen T.C., Chang J.T.C., Chan S.C., Ko S.F., Wang H.M., et al. Prospective study of [18F]Fluorodeoxuglucose positron emission tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 27 (2006) 4371-4376
18. Joeong H.S., Baek C.H., Son Y.I., Chung M.K., Lee D.K., Choi J.Y., et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 29 (2007) 203-210
19. Ross G.L., Soutar D.S., MacDonald D.G., Shoaib T., Camilleri I., Robertson A.G., et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 11 (2004) 690-696
20. Paleri V., Rees G., Allurendran P., Shoaib T., and Krishman S. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 27 (2005) 739-747
21. www.sent.eu.com.
22. Stoeckli S.J., Pfaltz M., Ross G., Steinert H.C., MacDonald D.G., Wittekind C., et al. The second international conference on sentinel node biopsy in head and neck cancer. Ann Surg Oncol 12 (2005) 919-924
23. Abdel Razek A.A.K., Soliman N.Y., Elkhamary S., Alsharaway M.K., and Tawfik A. Role of diffusion-weighted MRI imaging in cervical lymphadenopathy. Eur Radiol 16 (2006) 1468-1477
24. De Bondt R.B.J., Hoeberigs M.C., Nelemans P.J., Deserno W.M.L.L.G., Peutz-Kootstra C.P., Kremer B., et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 51 (2009) 183-192
25. Vandecaveye V., De Keyzer F., Van der Poorten V., Dirix P., Verbeken E., Nuyts S., et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MT imaging for nodal staging. Radiology 251 (2009) 134-146
26. Black R.J., Gluckman J.L., and Shumrick D.A. Screening for distant metastases in head and neck cancer patients. Aust N Z J Surg 54 (1984) 527-530
27. Jäckel M.C., and Rausch H. Fernmetastasierung von Plattenepithelkarzinom des oberen Aerodigestivtrakts. Der Einfluss klinischer Tumorparameter und des Krankheitsverlauf. HNO 47 (1999) 38-44
28. de Bree R., Deurloo E.E., Snow G.B., and Leemans C.R. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110 (2000) 397-400
29. Brouwer J., de Bree R., Hoekstra OS Golding R.P., Langendijk J.A., Castelijns J.A., et al. Screening for distant metastases in patients with head and neck cancer: is chest CT sufficient?. Laryngoscope 115 (2005) 1808-1812
30. Leibel S.A., Scott C.B., Mohiuddin M., Marcial V.A., Coia L.R., Davis L.W., et al. The effect of local-regional control on distant metastatic dissemnination in carcinoma of the head and neck. Results from an analysis of the RTOG head and neck database. Int J Radiat Oncol Biol Phys 21 (1991) 549-556
31. Merino O.R., Linberg R.D., and Fletcher G.H. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40 (1977) 145-151
32. Léon X., Quer M., Orus C., del Prado Venegas M., and Lopez M. Distant metastases in head and neck cancer patients who achieved local-regional control. Head Neck 22 (2000) 680-686
33. Leemans C.R., Tiwari R., Nauta J.J.P., van der Waal I., and Snow G.B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71 (1993) 452-456
34. Loh K.S., Brown D.H., Baker J.T., Gilbert R.W., Gullane P.J., and Irish J.C. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck 27 (2005) 990-994
35. Ljumanovic R., Langendijk J.A., Hoekstra O.S., Leemans C.R., and Castelijns J.A. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Eur J Radiol 60 (2006) 58-66
36. Brouwer J., Senft A., de Bree R., Comans E.F.I., Golding R.P., Castelijns J.A., et al. Screening for distant metastases in patients with head and neck cancer: is there a role for 18 FDG-PET?. Oral Oncol. 42 (2006) 275-280
37. Senft A., de Bree R., Hoekstra O.S., Kuik D.J., Golding R.P., Oyen W.J.G., et al. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multitcenter trial study. Radiother Oncol 87 (2008) 221-229
38. Ng S.H., Chan S.C., Liao C.T., Chang J.T., Ko S.F., Wang H.M., et al. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT. Neuroradiology 50 (2008) 969-979
39. Kim S.Y., Roh J.L., Yeo N.K., Kim J.S., Lee J.H., Choi S.H., et al. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol 18 (2007) 1698-1703
40. Gourin C.G., Watts T.L., Williams H.T., Patel V.S., Bilodeau P.A., and Coleman T.A. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Laryngoscope 118 (2008) 671-675
41. Herborn C.U., Unkel C., Vogt F.M., Massing S., Lauenstein T.C., and Neumann A. Whole-body MRI for staging patients with head and neck squamous cell carcinoma. Acta Otolaryngol 125 (2005) 1224-1229
42. Schmidt G.P., Baur-Melnyk A., Haug A., Heinemann V., Bauerfeind I., Reisser M.F., et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 6 (2008) 47-58
43. Lauenstein T.C., Goehde S.C., Herborn C.U., Goyen M., Oberhoff C., Debatin J.F., et al. Whole-body MR imaging; evaluation in patients for metastases. Radiology 233 (2004) 139-148
44. Müller-Horvat C., Radny P., Eigentler T.K., Schäfer J., Pfannenberg C., Horger M., et al. Prospective comparison of the impact on treatment decisions of whole body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42 (2006) 342-350
45. Ohno Y., Koyama H., Onishi Y., Takenaka D., Nogami M., Yoshikawa T., et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248 (2008) 643-654